Lebanon occupies a unique position in the MENA market research landscape. Despite the severe economic crisis that has reshaped the country since 2019, Lebanon retains extraordinary intellectual capital: world-class medical institutions including the American University of Beirut Medical Center (AUBMC) and Lebanese American University Medical Center, a large diaspora of internationally trained researchers and physicians, and a trilingual Arabic-French-English professional workforce that is unparalleled in the region. For research buyers, Lebanon remains a viable and often cost-effective market for primary research — provided the right local partner with operational resilience is engaged.
The Ministry of Public Health Lebanon (MoPH) oversees pharmaceutical registration, pricing, and market access. Lebanon's pharmaceutical market, though significantly contracted from its pre-crisis peak, still features a sophisticated distribution network, an established Syndicate of the Order of Physicians, and an active community of specialist and academic clinicians. The concentration of hospitals — Beirut alone has more hospital beds per capita than most Arab capitals — and academic medical research centres creates excellent conditions for KOL mapping, physician advisory boards, and health outcomes research that can generate regionally relevant insights.
Lebanon's historically strong role as a pharma distribution and research hub for the Levant and wider MENA — pre-crisis Beirut was the regional headquarters for numerous multinational pharmaceutical and FMCG companies — means that experienced research professionals, established physician networks, and institutional research relationships still exist and can be accessed with the right partner. The ongoing recovery and reconstruction context creates new research needs around consumer sentiment, economic behaviour, and market re-entry strategy. A research partner for Lebanon must understand the MoPH regulatory environment, navigate the trilingual research complexity, and leverage Lebanon's unique strengths despite current economic constraints.